SCHEMBL7095977

SCHEMBL7095977

c1ccc2c(Nc3cc(C4CC4)n[nH]3)nc(Nc3ccc(N4CCOCC4)cc3)nc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.56
KDM4E B2RXH2 4/20 0.56
MAPT P10636 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KDM1A O60341 1/20 0.53
ULK1 O75385 1/20 0.49
LMNA P02545 4/20 0.49
HPGD P15428 3/20 0.49
TSHR P16473 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
ALDH1A1 P00352 2/20 0.48
HTT P42858 2/20 0.48
ALOX15 P16050 1/20 0.48
HSD17B10 Q99714 1/20 0.48
BRD4 O60885 2/20 0.47
IGF1R P08069 3/20 0.47
BRD2 P25440 1/20 0.47
BRD3 Q15059 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2204246 0.86 ULK1 (0.57) ULK1MERTK
SCHEMBL12430712 0.84 ULK1 (0.72) ULK1IGF1R
SCHEMBL2202078 0.81 ULK1 (0.52) ULK1MERTK
SCHEMBL11342140 0.81 IGF1R (0.71) ULK1IGF1R
SCHEMBL11341033 0.81 IGF1R (0.71) BRD4IGF1R
SCHEMBL2202089 0.80 SLC2A1 (0.53) MEN1KMT2AULK1MERTK
SCHEMBL2204494 0.80 ULK1 (0.51) ULK1MERTK
SCHEMBL2200909 0.80 ULK1 (0.51) KDM4EMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL2203860 0.79 ULK1 (0.49) ULK1
SCHEMBL2205394 0.79 PDE4B (0.50) ULK1MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355905-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2003-10-29 EP disclosed
EP-1353916-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-10-22 EP disclosed
EP-1345926-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-09-24 EP disclosed
EP-1345925-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-09-24 EP disclosed
WO-2002068415-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-09-06 WO disclosed
WO-2002059111-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-08-01 WO disclosed
WO-2002057259-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-07-25 WO disclosed
WO-2002050065-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-06-27 WO disclosed